Our Purpose

Advancing science. Improving lives. Scaling global solutions.

Veos Pharmaceuticals develops and commercializes biotechnology solutions across human health, agriculture, and environmental systems — built on scientific rigor, manufactured in Europe, distributed worldwide.

Scroll

Three core areas of focus, built on scientific rigor and commercial execution.

Building the next generation of science-led consumer and clinical brands.

Ophthalmic · 2026 PROJECT // OPH-2026-EU
Press · June 2026

Veos Pharmaceuticals Secures Innowwide Call 4 / Eureka Funding to Bring BioPropello™ to Japan

Veos Pharmaceuticals has secured funding under the Innowwide Call 4 programme of the Eureka Network for BIOPRO-JP (ref. 2025-25398), ...

Region
EU-Japan
Category
Agriculture
Stage
POC
Read the announcement

Press, research, and progress updates from across the company.

Partnership11 / 2025

Veos Pharmaceuticals Expands North American Presence with Acquisition of SSD Trading Canada's Amazon Wellness Portfolio.

Read article →
Research01 / 2025

Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys

Read article →
Sustainability08 / 2025

Veos Pharmaceuticals Participating in Smart Energy Week Autumn 2025 Business Mission — Veos Pharmaceuticals.

Read article →
Collaborate

Partner with Veos.

We collaborate with global partners — clinicians, distributors, growers, and research institutions — to scale innovation into real-world applications.

Contact our team About Veos